Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: A report from the children's oncology group

Journal of Pediatric Surgery

Volumn 45, Issue 11, 2010, Pages 2160-2168

  Raney, Beverly ^a,b,l   Stoner, Julie ^c,d   Anderson, James ^c   Andrassy, Richard ^a   Arndt, Carola ^e   Brown, Ken ^f   Crist, William ^g   Maurer, Harold ^c   Qualman, Stephen ^h   Wharam, Moody ⁱ   Wiener, Eugene ^j   Meyer, William ^k   Hayes Jordan, Andrea ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Children's Medical Center   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g University of Missouri   (United States)

^h NATIONWIDE CHILDREN S HOSPITAL   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^l NONE   (United States)

more..

Author keywords

Childhood rhabdomyosarcoma; IRS IV protocol; Second look procedures

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ARTICLE; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; HEAD TUMOR; HUMAN; LAPAROTOMY; LIMB TUMOR; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; ORBIT TUMOR; PELVIS TUMOR; PRIORITY JOURNAL; PROSTATE TUMOR; PROSTATECTOMY; RADIODIAGNOSIS; RETROPERITONEAL TUMOR; RHABDOMYOSARCOMA; SECOND LOOK SURGERY; SOFT TISSUE SARCOMA; SURVIVAL RATE; TRANSURETHRAL RESECTION;

ANTINEOPLASTIC AGENTS; CHILD; DIAGNOSTIC IMAGING; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA; SECOND-LOOK SURGERY; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 78049462132     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.07.021     Document Type: Article

References (17)

1. Maurer H.M., Beltangady M., and Gehan E.A. The Intergroup Rhabdomyosarcoma Study-I: A final report Cancer 61 1988 209 220
2. Maurer H.M., Gehan E.A., and Beltangady M. The Intergroup Rhabdomyosarcoma Study-II Cancer 71 1993 1904 1922
3. Crist W., Gehan E.A., and Ragab A.H. The Third Intergroup Rhabdomyosarcoma Study J Clin Oncol 13 1995 610 630
4. Crist W.M., Anderson J.R., and Meza J.L. Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease J Clin Oncol 19 2001 3091 3102
5. Donaldson S.S., Meza J., and Breneman J.C. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma-a report from the IRSG Int J Radiat Oncol Biol Phys 51 2001 718 728
6. Arndt C.A.S., Hammond S., and Rodeberg D. Significance of persistent mature rhabdomyoblasts in bladder/prostate rhabdomyosarcoma. Results from IRS IV J Pediatr Hematol Oncol 28 2006 563 567
7. Anderson J.R. Commonly misused approaches in the analysis of cancer clinical trials J. Crowley, Handbook of statistics in clinical oncology 2001 Marcel Dekker, Inc. New York, NY 491 502
8. Kaplan G.L., and Meier P. Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
9. Peto R., Pike M.C., and Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: analysis and examples Br J Cancer 35 1958 1 39
10. Cox D.R. Regression models and life tables J Roy Stat Soc, Series B 34 1972 187 220
11. Arndt C., Rodeberg D., and Breitfeld P.P. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from Intergroup Rhabdomyosarcoma Study IV J Urol 171 2004 2396 2403
12. Wiener E., Lawrence W., and Hays D. Survival is improved in Clinical Group III children with complete response (CR) established by second-look operations in the Intergroup Rhabdomyosarcoma Study (IRS) III Med Pediatr Oncol 19 1991 399 (Abstract 228)
13. Treuner J., Suder J., and Keim M. The predictive value of initial cytostatic response in primary unresectable rhabdomyosarcoma in children Acta Oncologica 28 1989 67 72
14. Godzinski J., Flamant F., and Rey A. Value of postchemotherapy bioptical verification of complete clinical remission in previously incompletely resected (stage I and II pT3) malignant mesenchymal tumors in children: International Society of Pediatric Oncology 1984 Malignant Mesenchymal Tumors Study Med Pediatr Oncol 22 1994 22 26
15. Cecchetto G., Bisogno G., and Treuner J. Role of surgery for nonmetastatic abdominal rhabdomyosarcomas. A report from the Italian and German Soft Tissue Cooperative Groups studies Cancer 97 2003 1974 1980
16. Cecchetto G., Carretto E., and Bisogno G. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: a report from the AEIOP Soft Tissue Sarcoma Committee Pediatr Blood Cancer 51 2008 593 597
17. Rodeberg D.A., Stoner J.A., and Hayes-Jordan A. Prognostic significance of tumor response at the end of therapy in Group III rhabdomyosarcoma: a report from the Children's Oncology Group J Clin Oncol 27 2009 3705 3711